You are viewing: Rest Of Asia Pacific Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Rest Of Asia Pacific Long Read Sequencing Market was valued at $23 Million in 2024 and projected to reach to $104.3 Million by 2029, representing a compound annual growth rate of 35.3%. Rest Of Asia Pacific represents one of the most dynamic segments in the global long read sequencing market, with exceptional growth momentum driven by healthcare infrastructure development and increased genomic research funding.

Rest Of Asia Pacific Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Asia Pacific Long Read Sequencing Market Trends and Insights

  • Rest Of Asia Pacific represents a high-growth region driven by increasing adoption of genomic technologies, rising healthcare investments, and growing demand for precision medicine applications.
  • The region's market trajectory reflects accelerating clinical adoption and expanding research capabilities across emerging economies. Rest Of Asia Pacific's 35.3% compound annual growth rate significantly outpaces global trends, positioning the region as a critical growth engine for long read sequencing technologies.
  • Rest Of Asia Pacific is witnessing substantial infrastructure development, increased government funding for genomic research, and growing partnerships between academic institutions and commercial sequencing providers.
  • By 2029, Rest Of Asia Pacific is expected to capture a substantially larger share of the global long read sequencing market, driven by population scale, rising disease prevalence, and improving healthcare accessibility..

Key Market Statistics

  • CAGR (2024-2029) 35.3% CAGR
  • Market Size, 2024 ~USD 23 Million
  • Forecast, 2029 ~USD 104.3 Million
  • Country Rest Of Asia Pacific

Rest Of Asia Pacific Long Read Sequencing Market Overview

Rapid Market Expansion :

Rest Of Asia Pacific's long read sequencing market is growing at 35.3% CAGR, outpacing the global average of 32.8%, driven by increasing genomic research initiatives and healthcare modernization across emerging economies in the region.

Significant Revenue Growth :

Market valuation is projected to surge from $23.0 million in 2024 to $104.3 million by 2029, representing a 353% increase over five years, reflecting strong regional demand for advanced sequencing technologies.

Precision Medicine Adoption :

Growing demand for precision medicine applications in Rest Of Asia Pacific is accelerating long read sequencing adoption, with healthcare providers increasingly investing in genomic diagnostics for personalized treatment strategies.

Healthcare Investment Surge :

Rising healthcare expenditures and government support for genomic research infrastructure across Rest Of Asia Pacific countries are creating favorable conditions for long read sequencing market penetration and technology deployment.

Rest Of Asia Pacific Long Read Sequencing Market Dynamics

  • The region's emerging economies are rapidly adopting advanced sequencing technologies as precision medicine becomes integral to clinical practice and drug development initiatives. Key growth catalysts include expanding research institutions, rising prevalence of genetic disorders, and government initiatives promoting genomic medicine adoption.
  • With a projected CAGR of 35.3% through 2029, Rest Of Asia Pacific is positioned as a critical growth engine for long read sequencing vendors, offering substantial opportunities for market expansion and technology localization..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Rest Of Asia Pacific long read sequencing market valued at $23.0M in 2024, expanding to $104.3M by 2029 at 35.3% CAGR
    • Rest Of Asia Pacific growth rate exceeds global average, driven by genomic infrastructure investment and precision medicine adoption
    • Rest Of Asia Pacific emerging economies are establishing sequencing centers and expanding research capabilities across the region
    • Rest Of Asia Pacific market expansion supported by government initiatives, academic partnerships, and increasing clinical applications

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Rest Of Asia Pacific Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Sequencing Technology Vendors : Long read sequencing platform manufacturers need Rest Of Asia Pacific market intelligence to identify high-growth opportunities, optimize product positioning, and develop localized commercialization strategies for emerging markets.
    • Healthcare & Diagnostic Companies : Clinical laboratories and diagnostic service providers require regional market data to assess demand for long read sequencing services, plan capacity investments, and understand competitive dynamics in Rest Of Asia Pacific.
    • Investment & Private Equity Firms : Investors evaluating genomics and healthcare technology opportunities in Asia Pacific need detailed market forecasts and growth metrics for Rest Of Asia Pacific to support due diligence and portfolio decisions.
    • Research Institutions & Academic Centers : Universities and research organizations in Rest Of Asia Pacific require market insights to secure funding, justify technology investments, and align genomic research initiatives with regional market trends and opportunities.
    • Healthcare Policy & Government Bodies : Government agencies and health ministries in Rest Of Asia Pacific need market intelligence to inform genomic medicine policies, healthcare infrastructure planning, and precision medicine adoption initiatives across the region.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to Rest Of Asia Pacific ($23.0M in 2024, $104.3M by 2029) with detailed year-by-year projections to support strategic planning and investment decisions in this high-growth region.
    • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning within Rest Of Asia Pacific's long read sequencing sector to identify partnership opportunities and market entry strategies tailored to regional conditions.
    • Growth Driver Analysis : Gain insights into region-specific growth catalysts including healthcare investments, precision medicine adoption, and genomic research initiatives driving the 35.3% CAGR in Rest Of Asia Pacific.
    • Customer Segmentation & Demand Patterns : Access detailed analysis of Rest Of Asia Pacific customer segments—research institutions, diagnostic labs, and healthcare providers—with specific demand patterns and adoption timelines for long read sequencing technologies.
    • Strategic Market Entry Roadmap : Develop region-specific go-to-market strategies with actionable insights on regulatory environments, reimbursement landscapes, and technology adoption barriers unique to Rest Of Asia Pacific markets.

    Frequently asked questions

    What is the current market size of long read sequencing in Rest Of Asia Pacific?

    Rest Of Asia Pacific long read sequencing market was valued at $23.0 million in 2024 and is projected to grow to $104.3 million by 2029.

    What is the growth rate for long read sequencing in Rest Of Asia Pacific?

    Rest Of Asia Pacific is experiencing a compound annual growth rate of 35.3% from 2024 to 2029, significantly outpacing global market growth.

    What factors are driving growth in Rest Of Asia Pacific long read sequencing market?

    Rest Of Asia Pacific growth is driven by increasing healthcare investments, rising adoption of genomic technologies, government funding for research, and expanding precision medicine applications.

    Which countries in Rest Of Asia Pacific are leading market adoption?

    Rest Of Asia Pacific includes emerging economies establishing genomic research centers and clinical sequencing capabilities, with growth concentrated in countries with strong healthcare infrastructure investments.

    How does Rest Of Asia Pacific market growth compare to other regions?

    Rest Of Asia Pacific's 35.3% CAGR exceeds the global average of 32.8%, positioning the region as one of the fastest-growing markets for long read sequencing technology.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status